Fundz

Bridge Therapeutics reported raising $321,000 in an initial SEC Form D filing, from an offering of $1.5 Million

PRIVATEDec 18, 2023$321K of $1.5M raised

Amount Raised

$321,000

$321,000 sold, per SEC Form D (first sale Oct 27, 2023)

Round Type

Seed

BirminghamHealthcarePharmaceutical Manufacturing

Quick answer

Bridge Therapeutics raised $321,000 in a Seed round, dated October 27, 2023. Bridge Therapeutics is based in Birmingham, Alabama, United States.

How much did Bridge Therapeutics raise?
Bridge Therapeutics raised $321,000 in a Seed round on October 27, 2023.
What does Bridge Therapeutics do?
Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a..
Where is Bridge Therapeutics based and how big is it?
Bridge Therapeutics is based in Birmingham, Alabama, United States.
Who are the decision-makers at Bridge Therapeutics?
Fundz holds 1 contact at Bridge Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Pharmaceutical Manufacturing around the same time

Companies in the same sectors as Bridge Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Panbela Therapeutics raised $3.3M (Seed) on November 2, 2023.
  • Physician 360, Inc. raised $3.1M (Seed) on December 11, 2023.
  • TuHURA Biosciences raised $1.7M (Seed) on December 11, 2023.
  • Imagen Dental Partners raised $620K (Seed) on December 11, 2023.
  • Medefy Health raised $10M (Series A) on December 11, 2023.
  • NextVein raised $570K (Seed) on December 11, 2023.

Who to call at Bridge Therapeutics, and when

A new round usually means Bridge Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bridge Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bridge Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bridge Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bridge Therapeutics

Location

217 COUNTRY CLUB PARK, STE

Birmingham, Alabama, United States

About

Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chronic pain in opioid-experienced patients. The investigational drug BT-205 is a unique combination of two synergistic chronic pain drugs—the partial-agonist opioid buprenorphine and the NSAID meloxicam—delivered in a state-of-the-art sublingual formulation. The dosing and delivery method will be a commercial advantage over the current alternatives. Bridge Therapeutics'​ goal is to make the BT-205 compound and other investigational new drug candidates available to millions of patients in which addictive and potentially dangerous full-agonist opioids such as oxycodone and morphine are ineffective and/or unsatisfactory. For more information, visit www.bridgetherapeutics.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bridge Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts28 people are listed at Bridge Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Bridge Therapeutics's next move

See what Strategic adds

Bridge Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.